Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Acarbose 100mg
Bayer New Zealand Limited
Acarbose 100 mg
100 mg
Tablet
Active: Acarbose 100mg Excipient: Colloidal silicon dioxide Magnesium stearate Maize starch Microcrystalline cellulose
Blister pack, polypropylene, 90 tablets
Prescription
Prescription
Bayer AG
Glucobay is indicated for the additional treatment of insulin dependant and non-insulin dependant diabetes mellitus in association with diet.
Package - Contents - Shelf Life: Blister pack, PA/Alu/PVC - 90 tablets - 36 months from date of manufacture stored at or below 30°C - Blister pack, Polypropylene/Alu - 90 tablets - 36 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC/Alu - 90 tablets - 36 months from date of manufacture stored at or below 25°C
1993-12-16
GLUCOBAY ® CMI 1 GLUCOBAY ® (GLUE·CO·BAY) _acarbose_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Glucobay. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Glucobay against the benefits they expect it will have for you. As Glucobay is a prescription medicine, it should only be used under medical supervision. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT GLUCOBAY IS USED FOR Glucobay tablets contain the active drug acarbose. They are used for the treatment of diabetes . Glucobay helps to control your blood sugar levels in conjunction with diet, exercise, weight loss and other measures by slowing down the digestion of carbohydrates (complex sugars) from your diet. This reduces the abnormally high blood sugar levels that occur after each meal. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. BEFORE YOU TAKE GLUCOBAY _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE GLUCOBAY IF YOU HAVE AN ALLERGY TO: • acarbose, the active ingredient in Glucobay • any of the ingredients listed at the end of this leaflet. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. DO NOT TAKE GLUCOBAY IF: • you have a severe kidney disorder (creatinine clearance < 25 mL/min). • you suffer from intestinal obstruction, inflammation or ulceration of the bowel, e.g. ulcerative colitis or Crohn’s disease. • you have a hernia or have had previous abdominal surgery. If so, consult your doctor first. DO NOT GIVE THIS MEDICINE TO A CHILD UNDER THE AGE OF Read the complete document
DATA SHEET GLUCOBAY ® _ACARBOSE TABLETS 50 MG AND 100 MG OBLONG _ QUALITATIVE AND QUANTITATIVE COMPOSITION Glucobay 50 1 tablet contains 50 mg acarbose Glucobay 100 1 tablet contains 100 mg acarbose PHARMACEUTICAL FORM Glucobay 50 Tablets Glucobay 100 Tablets TABLETS 50 MG : White to yellow-tinged round, convex tablets of 7 mm diameter and 10 mm radius of curvature. On one side the tablet code is “G” and “50” and on the other side “Bayer cross”. OBLONG TABLETS 100 MG : White to yellow-tinged oval oblong, convex tablets of 13 mm length, 6 mm width and 5.5 mm radius of curvature. On one side the tablet code is “G”, ”score” and “100” and on the other side “score”. INDICATIONS Glucobay is indicated for the additional treatment of insulin dependant and non-insulin dependant diabetes mellitus in association with diet. POSOLOGY AND METHOD OF ADMINISTRATION _RECOMMENDED USUAL DOSE FOR ADDITIONAL THERAPY IN ASSOCIATION WITH DIET IN PATIENTS WITH DIABETES _ _MELLITUS _ Because efficacy and tolerability vary, the dosage must be adjusted by the doctor to suit each individual patient. _DOSAGE REGIMEN _ Unless otherwise prescribed the recommended dosage is as follows: Initially 3 x 1 tablet of 50 mg Glucobay/day or 3 x ½ tablet of 100mg Glucobay/day Up to 3 x 2 tablets of 50 mg Glucobay/day or 3 x 1 tablet of 100mg Glucobay/day A further increase in dosage to 3 x 200 mg Glucobay/day may occasionally be necessary. The dose may be increased after 4 – 8 weeks. An increase can also be made later in the course of the treatment if the patient shows an inadequate clinical response. If side effects occur in spite of strict adherence to the diet, the dose should not be increased, and if necessary should be reduced. The average Glucobay Data Sheet 1 dose is 300mg Glucobay/day (corresponding to 3 x 2 tablets of Glucobay 50 /day, or 3 x 1 tablet of Glucobay 100 /day). _METHOD OF ADMINISTRATION _ Glucobay tablets are effective only if swallowed whole with a little liquid directly before the meal or chewed wi Read the complete document